Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

BACKGROUND: This study aimed to assess the characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain in comparison with patients receiving at least 60 mg of oral morphine equivalents (OME). MATERIALS AND METHODS: Patients with advanced cancer r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Mercadante, Sebastiano, Caraceni, Augusto, Masedu, Francesco, Scipioni, Teresa, Aielli, Federica
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011660/
https://ncbi.nlm.nih.gov/pubmed/31862860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados